These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9579827)

  • 1. The antiproliferative activity of all-trans-retinoic acid catabolites and isomers is differentially modulated by liarozole-fumarate in MCF-7 human breast cancer cells.
    Van heusden J; Wouters W; Ramaekers FC; Krekels MD; Dillen L; Borgers M; Smets G
    Br J Cancer; 1998 Apr; 77(8):1229-35. PubMed ID: 9579827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of liarozole, a new antitumoral compound, on retinoic acid-induced inhibition of cell growth and on retinoic acid metabolism in MCF-7 human breast cancer cells.
    Wouters W; van Dun J; Dillen A; Coene MC; Cools W; De Coster R
    Cancer Res; 1992 May; 52(10):2841-6. PubMed ID: 1581897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. All-trans-retinoic acid metabolites significantly inhibit the proliferation of MCF-7 human breast cancer cells in vitro.
    Van heusden J; Wouters W; Ramaekers FC; Krekels MD; Dillen L; Borgers M; Smets G
    Br J Cancer; 1998; 77(1):26-32. PubMed ID: 9459142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liarozole potentiates the all-trans-retinoic acid-induced structural remodelling in human breast carcinoma MCF-7 cells in vitro.
    Van heusden J; Borgers M; Ramaekers F; Xhonneux B; Wouters W; De Coster R; Smets G
    Eur J Cell Biol; 1996 Sep; 71(1):89-98. PubMed ID: 8884182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of the oxidative catabolism of retinoid acid in MCF-7 cells.
    Krekels MD; Verhoeven A; van Dun J; Cools W; Van Hove C; Dillen L; Coene MC; Wouters W
    Br J Cancer; 1997; 75(8):1098-104. PubMed ID: 9099955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of all-TRANS-retinoic acid metabolism by R116010 induces antitumour activity.
    Van Heusden J; Van Ginckel R; Bruwiere H; Moelans P; Janssen B; Floren W; van der Leede BJ; van Dun J; Sanz G; Venet M; Dillen L; Van Hove C; Willemsens G; Janicot M; Wouters W
    Br J Cancer; 2002 Feb; 86(4):605-11. PubMed ID: 11870544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel retinoic acid metabolism blocking agents endowed with multiple biological activities are efficient growth inhibitors of human breast and prostate cancer cells in vitro and a human breast tumor xenograft in nude mice.
    Patel JB; Huynh CK; Handratta VD; Gediya LK; Brodie AM; Goloubeva OG; Clement OO; Nanne IP; Soprano DR; Njar VC
    J Med Chem; 2004 Dec; 47(27):6716-29. PubMed ID: 15615521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liarozole acts synergistically with 1alpha,25-dihydroxyvitamin D3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity.
    Ly LH; Zhao XY; Holloway L; Feldman D
    Endocrinology; 1999 May; 140(5):2071-6. PubMed ID: 10218956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P450-dependent enzymes as targets for prostate cancer therapy.
    De Coster R; Wouters W; Bruynseels J
    J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):133-43. PubMed ID: 8603034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liarozole fumarate inhibits the metabolism of 4-keto-all-trans-retinoic acid.
    Van Wauwe J; Coene MC; Cools W; Goossens J; Lauwers W; Le Jeune L; Van Hove C; Van Nyen G
    Biochem Pharmacol; 1994 Feb; 47(4):737-41. PubMed ID: 8129749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liarozole inhibits human epidermal retinoic acid 4-hydroxylase activity and differentially augments human skin responses to retinoic acid and retinol in vivo.
    Kang S; Duell EA; Kim KJ; Voorhees JJ
    J Invest Dermatol; 1996 Aug; 107(2):183-7. PubMed ID: 8757760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.
    Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG
    Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel therapeutic approach: organic arsenical melarsoprol) alone or with all-trans-retinoic acid markedly inhibit growth of human breast and prostate cancer cells in vitro and in vivo.
    Koshiuka K; Elstner E; Williamson E; Said JW; Tada Y; Koeffler HP
    Br J Cancer; 2000 Jan; 82(2):452-8. PubMed ID: 10646904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental studies with liarozole (R 75,251): an antitumoral agent which inhibits retinoic acid breakdown.
    De Coster R; Wouters W; Van Ginckel R; End D; Krekels M; Coene MC; Bowden C
    J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):197-201. PubMed ID: 1525060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome p450 retinoic acid 4-hydroxylase inhibitors: potential agents for cancer therapy.
    Njar VC
    Mini Rev Med Chem; 2002 Jun; 2(3):261-9. PubMed ID: 12370067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel retinoic acid metabolism blocking agents have potent inhibitory activities on human breast cancer cells and tumour growth.
    Patel JB; Mehta J; Belosay A; Sabnis G; Khandelwal A; Brodie AM; Soprano DR; Njar VC
    Br J Cancer; 2007 Apr; 96(8):1204-15. PubMed ID: 17387344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of all-trans retinoic acid pharmacokinetics by liarozole.
    Miller VA; Rigas JR; Muindi JR; Tong WP; Venkatraman E; Kris MG; Warrell RP
    Cancer Chemother Pharmacol; 1994; 34(6):522-6. PubMed ID: 7923564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liarozole, an inhibitor of retinoic acid metabolism, exerts retinoid-mimetic effects in vivo.
    Van Wauwe J; Van Nyen G; Coene MC; Stoppie P; Cools W; Goossens J; Borghgraef P; Janssen PA
    J Pharmacol Exp Ther; 1992 May; 261(2):773-9. PubMed ID: 1374473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liarozole amplifies retinoid-induced apoptosis in human prostate cancer cells.
    Hall AK
    Anticancer Drugs; 1996 May; 7(3):312-20. PubMed ID: 8792006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of retinoid status on the messenger ribonucleic acid expression of nuclear retinoid receptors alpha, beta, and gamma, and retinoid X receptors alpha, beta, and gamma in the mouse testis.
    Gaemers IC; van Pelt AM; van der Saag PT; Hoogerbrugge JW; Themmen AP; de Rooij DG
    Endocrinology; 1997 Apr; 138(4):1544-51. PubMed ID: 9075714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.